Giulia C. Kennedy - Mar 3, 2022 Form 4/A - Amendment Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Scientific & Med Officer
Signature
/s/ Jane Alley as attorney-in-fact
Stock symbol
VCYT
Transactions as of
Mar 3, 2022
Transactions value $
-$552,181
Form type
4/A - Amendment
Date filed
3/9/2022, 07:46 PM
Date Of Original Report
Mar 7, 2022
Previous filing
Mar 4, 2022
Next filing
Jun 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Award $0 +42.4K +112.87% $0.00 80K Mar 3, 2022 Direct F1
transaction VCYT Common Stock Options Exercise $26.4K +4.41K +5.51% $5.98 84.4K Mar 4, 2022 Direct F2
transaction VCYT Common Stock Sale -$426K -17.1K -20.25% $24.91 67.3K Mar 4, 2022 Direct F2, F3
transaction VCYT Common Stock Sale -$150K -5.84K -8.68% $25.70 61.5K Mar 4, 2022 Direct F2, F4
transaction VCYT Common Stock Sale -$2.65K -100 -0.16% $26.49 61.4K Mar 4, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCYT Stock Option (right to buy) Award $0 +77.3K $0.00 77.3K Mar 3, 2022 Common Stock 77.3K $26.02 Direct F5
transaction VCYT Stock Option (right to buy) Options Exercise $0 -4.41K -100% $0.00* 0 Mar 4, 2022 Common Stock 4.41K $5.98 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units awarded on March 3, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
F2 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021.
F3 Represents weighted average sales price. Sale prices for the transactions range from $24.40 to $25.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F4 Represents weighted average sales price. Sale prices for the transactions range from $25.41 to $26.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F5 The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
F6 The option is fully vested.

Remarks:

This amendment to Form 4 filed on March 7, 2022 is filed to correct the amount of securities sold on March 4, 2022 and the sale price applicable thereto as reflected in Column 4 of Table 1.